Patents by Inventor Hengmiao (Henry) Cheng

Hengmiao (Henry) Cheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRICYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS
    Publication number: 20120095062
    Abstract: The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
    Type: Application
    Filed: December 21, 2011
    Publication date: April 19, 2012
    Applicant: Pfizer Inc.
    Inventors: Hengmiao (Henry) CHENG, Xiao HU, Kenvin D. JEROME, Mark OBUKOWICZ, Lisa OLSON, Paul V. RUCKER, Ronald Keith WEBBER
  • TRICYCLIC COMPOUNDS, COMPOSITIONS AND METHODS
    Publication number: 20120088802
    Abstract: The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
    Type: Application
    Filed: May 8, 2009
    Publication date: April 12, 2012
    Applicant: Pfizer, Inc.
    Inventors: Hengmiao (Henry) Cheng, Xiao Hu, Kevin D. Jerome, Mark Obukowicz, Lisa Olson, Paul V. Rucker, Ronald Keith Webber
  • TRICYCLIC COMPOUNDS, COMPOSITIONS AND METHODS
    Publication number: 20100286214
    Abstract: The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
    Type: Application
    Filed: May 8, 2009
    Publication date: November 11, 2010
    Applicant: Pfizer, Inc.
    Inventors: Hengmiao (Henry) Cheng, Xiao Hu, Kevin D. Jerome, Mark Obukowicz, Lisa Olson, Paul V. Rucker, Ronald Keith Webber
  • Tricyclic compounds, compositions and methods
    Patent number: 7786097
    Abstract: The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
    Type: Grant
    Filed: July 21, 2009
    Date of Patent: August 31, 2010
    Assignee: Pfizer Inc.
    Inventors: Hengmiao (Henry) Cheng, Rajesh Devraj, Gary A Decresenzo, Xiao Hu, Kevin D. Jerome, Mark Obukowicz, Lisa Olson, Paul V. Rucker, Ronald Keith Webber
  • TRICYCLIC COMPOUNDS, COMPOSITIONS AND METHODS
    Publication number: 20090281148
    Abstract: The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
    Type: Application
    Filed: July 21, 2009
    Publication date: November 12, 2009
    Applicant: Pfizer,Inc.
    Inventors: Hengmiao (Henry) Cheng, Rajesh Devraj, Gary A. Decresenzo, Xiao Hu, Kevin D. Jerome, Mark Obukowicz, Lisa Olson, Ronald Keith Webber
  • Tricyclic compound, compositions, and methods
    Patent number: 7598231
    Abstract: The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
    Type: Grant
    Filed: January 31, 2008
    Date of Patent: October 6, 2009
    Assignee: Pfizer, Inc.
    Inventors: Hengmiao (Henry) Cheng, Rajesh Devraj, Gary A DeCresenzo, Xiao Hu, Kevin D. Jerome, Mark Obukowicz, Lisa Olson, Paul V. Rucker, Ronald Keith Webber
  • Tricyclic compounds, compositions, and methods
    Patent number: 7547714
    Abstract: The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
    Type: Grant
    Filed: January 31, 2008
    Date of Patent: June 16, 2009
    Assignee: Pfizer, Inc.
    Inventor: Hengmiao (Henry) Cheng
  • Tricyclic Compounds, Compositions, and Methods
    Publication number: 20080312294
    Abstract: The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
    Type: Application
    Filed: January 31, 2008
    Publication date: December 18, 2008
    Applicant: Pfizer, Inc.
    Inventors: Hengmiao (Henry) Cheng, Xiao Hu, Kevin D. Jerome, Mark Obukowicz, Lisa Olson, Paul V. Rucker, Ronald Keith Webber
  • Tricyclic Compound, Compositions, and Methods
    Publication number: 20080188443
    Abstract: The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
    Type: Application
    Filed: January 31, 2008
    Publication date: August 7, 2008
    Applicant: Pfizer, Inc.
    Inventors: Hengmiao (Henry) Cheng, Rajesh Devraj, Gary A. DeCresenzo, Xiao Hu, Kevin D. Jerome, Mark Obukowicz, Lisa Olson, Paul V. Rucker, Ronald Keith Webber